Atezolizumab proven safe, effective in understudied urinary tract carcinoma patients
A recent study has demonstrated the safety and efficacy of atezolizumab in under-represented individuals with metastatic urinary tract carcinoma, specifically those with older age, renal impairment, or upper tract urothelial carcinoma.
Atezolizumab proven safe, effective in understudied urinary tract carcinoma patients
19 Jul 2021